Axitinib OverviewAxitinib (AG013736; trade name Inlyta) is a small molecule tyrosine kinase inhibitor developed by Pfizer. It has been shown to significantly inhibit growth of breast cancer in animal (xenograft) models and has shown partial responses in clinical trials with renal cell carcinoma (RCC) and several other tumour types. It was approved for RCC by the U.S. Food and Drug Administration after showing a modest increase in progression-free surviv...
Read more Axitinib Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Axitinib
Recent Axitinib Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
- Tablet: 1mg, 5mg
Other drugs which contain Axitinib or a similar ingredient: (1 result)
Related Axitinib Topics: